Not updated yet!
Janssen develops treatments for some of the most devastating disorders and complex medical challenges of our times, including cancer, hepatitis, HIV/AIDS, diabetes, arthritis, dementia, and mental disorders. We focus our research on five strategic pathological areas: oncology, neurosciences, infectious diseases and vaccines, immunology, and cardiovascular and metabolic disorders. Dr. Paul Janssen founded the company in 1953 with only one thing in mind: saving people’s lives thanks to the development of better medicines. Today, Janssen is one of the most innovative pharmaceutical companies in the world with more than 40,000 employees, 4,600 of which in Belgium.